Schneyer Mark C. bought ACAD

August 6, 2026 · Form 4 insider transaction

Schneyer Mark C. bought 14,292 shares of ACADIA Pharmaceuticals Inc. at $17.84 per share, a transaction worth $255.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
14,292
Price
$17.84
Total value
$255.0K
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 6, 2026
Filing dateAugust 7, 2026
Shares owned after82,120
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR